Navigation Links
LSU receives $2 million from NIH for biomedical sciences training for underrepresented students
Date:12/2/2013

LSU Professor Graca Vicente was recently awarded a grant of more than $2 million from the National Institutes of Health, or NIH, to continue Phase III of the Initiative for Maximizing Student Development, or IMSD. She is the Charles H. Barr Distinguished Professor of Chemistry and Professor of Chemotherapy/Materials in the Department of Chemistry at LSU.

"The renewal of Phase III of the IMSD Program is giving us the opportunity to continue to provide research training and career development for LSU students," said Vicente. "It is also an opportunity to build and promote faculty collaborations, develop partnerships with other training programs and increase minority representation in Ph. D. and post-Ph. D. programs across the world."

Vicente serves at the director of IMSD, which provides research training, academic development and career opportunities in the biomedical and behavioral sciences to underrepresented minority graduate and undergraduate students at LSU.

LSU is one of a select group of universities in the United States to establish this program. IMSD has been supported since 2004 by the National Institutes of Health and Phase III, the third round of funding for IMSD, is funded through 2018. Phase I included a $546,000 award for four years (2004-2008) and Phase II was a competitive renewal for the following four years of $970,000 thousand (2009-2013).

Phase III differs from Phases I and II because, in addition to supporting the research of LSU undergraduate students, it also supports graduate students conducting research in the biomedical or behavioral sciences.

IMSD works to consistently produce graduates who rank among the most highly talented, motivated and productive research scientists in the nation. The LSU IMSD Scholars pursue successful research careers and leadership positions, and are among the most sought-after candidates nationwide for entrance into Ph.D. or post-Ph.D. programs.

"The IMSD Program has very special value to me because I am myself a minority Latino/Hispanic woman in the basic sciences," said Vicente. "One of my personal goals has always been to increase minority representation in research, particularly in the basic sciences."

She received her doctoral degree in chemistry from the University of California-Davis in 1990. She completed postdoctoral fellowships at the University of Bourgogne in France (1991), the University of Geneva in Switzerland (1991-1993) and ITQB (Research Institute) in Portugal (1993).

Her research interests include synthesis and investigation of physiochemical and biological properties of new fluorescent pyrrole-based compounds and their development for application in biology and medicine, such as bio-imaging, diagnosis, photodynamic therapy and boron neutron capture therapy of cancer.


'/>"/>

Contact: Ashley Berthelot-Arceneaux
aberth4@lsu.edu
225-578-3870
Louisiana State University
Source:Eurekalert

Related biology news :

1. In search for a vaccine, IU biologist receives $2.3 million to explore chlamydia genomics
2. Renowned geneticist R. Rodney Howell receives ACMG Foundation Lifetime Achievement Award
3. UF receives $1 million from Keck Foundation to study mechanisms of inherited disease
4. Gladstone scientist Warner C. Greene receives Washington University School of Medicine Alumni Award
5. Carnegies Wolf B. Frommer receives Bogorad Award for Excellence in Plant Biology
6. UC Riverside plant cell biologist receives top scientific honor
7. UC Riverside receives grant for global health and development research
8. Washington University receives $8 million to lead international childhood malnutrition effort
9. SRI Sarnoffs Iris on the Move® N-Glance™ Identification System Receives Lenel Factory Certification
10. SF State biology department receives $1.5 million to support science teaching
11. Dr. Karen Lloyd receives WHOIs Holger W. Jannasch Visiting Scholar Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2016)... Minn. , Nov. 22, 2016   MedNet ... supports the entire spectrum of clinical research, is pleased ... Medical LiveWire Healthcare and Life Sciences Awards ... award caps off an unprecedented year of recognition and ... trials for over 15 years. iMedNet ...
(Date:11/17/2016)... Nov. 17, 2016  AIC announces that it has just released a new white ... require high-performance scale-out plus high speed data transfer storage solutions. Photo - ... ... ... Setting up a high performance computing or ...
(Date:11/14/2016)... 14, 2016  xG Technology, Inc. ("xG" or the ... wireless communications for use in challenging operating environments, announced ... 2016. Management will hold a conference call to discuss ... Eastern Time (details below). Key Recent Accomplishments ... million binding agreement to acquire Vislink Communication Systems. The ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... the FrontPanel SDK that provide essential device-to-computer interconnect using USB or PCI Express, ... require FrontPanel support. The FOMD-ACV-A4 is a small, thin, SODIMM-style module that fits ...
(Date:12/8/2016)... , ... December 08, 2016 ... ... the commercial launch of flexible packaging for their exceptionally efficient human mesenchymal ... system extends RoosterBio’s portfolio of bioprocess media products engineered to radically streamline ...
(Date:12/8/2016)...  HedgePath Pharmaceuticals, Inc. (OTCQX: HPPI), a clinical ... to commercialize innovative therapeutics for patients with cancer, ... approved for trading on the OTCQX U.S. market. ... effective today, under the ticker symbol "HPPI." ... must meet high financial standards, follow best practice ...
(Date:12/7/2016)... Diego (PRWEB) , ... December 07, 2016 , ... ... data from its phase I/II dose escalation and expansion clinical trial for its ... in Vienna, Austria. The purpose of the trial was to determine the safety, ...
Breaking Biology Technology: